Sorensen Mel
- SEC CIK
- 0001444783
In the past year, 1 open-market sale filing worth $1.41K and no purchases.
Current role at each company
- GRTX Galera Therapeutics, Inc.President and CEOas of Aug 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.41K
- 1 filing
- Net
- −$1.41K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sorensen Mel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 (view filing)4:42 PM ET | Nov 20 | 4 days | Sorensen MelPresident and CEO | SSale | −70.0K | $0.0201 | −$1.41K | −26.4%195.0K after | |
| Aug 20, 2024 (view filing)4:45 PM ET | Aug 16 | 4 days | Sorensen MelPresident and CEO | SSale | −67.0K | $0.072 | −$4.83K | −20.2%265.0K after | |
| Mar 14, 2023 (view filing) | Mar 10 | 4 days | Sorensen MelPresident and CEO | PPurchase | +100.0K | $1.68 | +$168.0K | +43.1%332.0K after |